Publications
134
Citations
2,740
Est. group size
—
Recurring co-author estimate
Active years
42
Publishing since 1984
Amanda Fisher conducts biomedical research centered on lung and cardiovascular diseases, with particular attention to pulmonary hypertension (high blood pressure in the vessels of the lungs) and lung fibrosis (scarring of lung tissue). This work uses animal models and molecular approaches to study disease mechanisms and potential treatments, including the role of the immune system's complement pathway and inflammatory signals in lung injury.
Publication activity has fluctuated across the decade, staying steady in recent years at roughly 5-6 papers per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
No award with a current end date on record.
2 earlier awards
- NSF 1754792Apr 2018 – Mar 2024 · $223k awarded
Collaborative Research: New World Justicia s.l.: A microcosm for understanding covariation of floral traits and pollinators in a phylogenetic context
- NSF 1802192Aug 2018 – Jul 2022 · $29k awarded
Digitization TCN: Collaborative Research: Capturing California's Flowers: using digital images to investigate phenological change in a biodiversity hotspot
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~6 · 0% small-team papers (≤3 authors) · across 10 venues
- Modulation of soluble guanylate cyclase ameliorates pulmonary hypertension in a rat model of chronic thromboembolic pulmonary hypertension by stimulating angiogenesis
Physiological Reports · 2022
- Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury
American Journal of Respiratory Cell and Molecular Biology · 2022
- Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae
Pathogens · 2020
- Histological and transcriptomic effects of 17α-methyltestosterone on zebrafish gonad development
BMC Genomics · 2017
- IL‐17A deficiency mitigates bleomycin‐induced complement activation during lung fibrosis
The FASEB Journal · 2017
- IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis
PMC · 2017
- P1529Poor mental health is accompanied by reduced autonomic functioning in the month following acute coronary syndrome
European Heart Journal · 2017
- Additional file 8: of Histological and transcriptomic effects of 17Îą-methyltestosterone on zebrafish gonad development
Figshare · 2017
- Additional file 6: of Histological and transcriptomic effects of 17Îą-methyltestosterone on zebrafish gonad development
Figshare · 2017
- Additional file 4: of Histological and transcriptomic effects of 17Îą-methyltestosterone on zebrafish gonad development
Figshare · 2017
- Additional file 7:ďťż of Histological and transcriptomic effects of 17Îą-methyltestosterone on zebrafish gonad development
Figshare · 2017
- Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis
Cellular & Molecular Medicine Open access · 2017
- Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis
IUScholarWorks (Indiana University) · 2017
- High Intensity Interval Training Benefits Right Heart Function in a Rat Model of Pulmonary Arterial Hypertension
IUScholarWorks (Indiana University) · 2016
- Circulation×6
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Medicine & Science in Sports & Exercise×5
- American Journal of Respiratory Cell and Molecular Biology×4
- Figshare×4
- László Farkas
Medicine · The Ohio State University
- Daniela Farkas
Medicine · The Ohio State University
- Vallerie V. McLaughlin
Medicine · University of Michigan
- Gary Long
Medicine · Indiana University
- Priscilla Correa‐Jaque
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile